Articles

New modelling demonstrates that supply of critical medicines for ventilating patients supports a return to elective surgery

The reforms will enable the safe and effective prescribing and use of opioids while maintaining access for patients who need them.

The TGA has initiated proceedings in the Federal Court of Australia in response to the alleged unlawful advertising of Miracle Mineral Supplement (MMS), dimethyl sulfoxide (DMSO) and other medicines by Southern Cross Directories Pty Ltd trading as MMS Australia

The TGA is reminding advertisers that therapeutic goods advertising must not undermine public health campaigns, as the cold and flu season begins in Australia and COVID-19 restrictions are eased

The TGA has issued four infringement notices totalling $50,400 to Brisbane based company Allpulse Technologies Pty Ltd

The TGA has issued a $12,600 infringement notice to Melbourne based company NutriPATH Pty Ltd for the alleged unlawful advertising of a COVID-19 Polymerase Chain Reaction (PCR) test collection kit.

Undertaking given to the Secretary of the Australian Government Department of Health for the purposes of section 42YL of the Act

The TGA has issued fifteen infringement notices totalling $37,800 to a doctor in Perth

Ads for health products are everywhere, but don't believe everything you read

The TGA has issued twelve infringement notices totalling $151,200 for the alleged unlawful advertising of Miracle Mineral Supplement and other medicines

From 1 July 2020, medicine advertisements in specified media do not need pre-approval from the TGA

Information updated

The TGA has issued an infringement notice for $2,520 to a woman in Western Australia for alleged breaches relating to COVID-19 test kits

The TGA has issued five infringement notices totalling $63,000 to a Queensland company for alleged breaches relating to COVID-19 test kits

Information on an exemption for radiopharmaceuticals that facilitates interstate supply during COVID-19

How to find information about the inactive ingredients in your medicines.

To improve access to important ingredient information, TGA publishes the names of excipients in medicines and biologicals on its website

In response to the COVID-19 pandemic, the TGA is implementing Serious Shortage Medicine Substitution Notices

The TGA has issued two infringement notices to Peter Evans' company totalling $25,200 for alleged breaches of therapeutic goods legislation in relation to the promotion of a 'BioCharger' device

The TGA has issued infringement notices totalling $25,200 to Queensland company CK Surgitech for alleged breaches relating to COVID-19 test kits

The TGA has issued an infringement notice for $2,520 to a woman in Western Australia for alleged breaches relating to COVID-19 test kits

The TGA has issued an infringement notice for $12,600 to Labtest Direct for the alleged advertising of COVID-19 Rapid Test kits

Clinicians need to tailor the device programming of CRT-D devices to each patient to ensure the delivery of therapy

The Federal Court granted the interim injunction on 3 April 2020

Interim statement concerning the use of GS1 Australia's Recall Health platform